| [1] |
Mathis CA, Holt DP, Wang Y, et al. 11C-labelled thioflavin-T analogues for amyloid plaques imaging in Alzheimer's disease[J]. J Label Compd Radiopharm, 2001, 44(1):26-28.
|
| [2] |
Mathis CA, Wang Y, Holt DP, et al. Synthesis and evaluation of 11C-labelled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents[J]. J Med Chem, 2003, 46(13):2740-2754.
|
| [3] |
Wilson AA, Garcia A, Chestakova A, et al. A rapid one-step radiosynthesis of the β-amyloid imaging radiotracer[11C]6-OH-BTA-1[J]. J Label Compd Radiopharm, 2004, 47:679-682.
|
| [4] |
Toyama H, Ye D, Ichise M, et al. PET imaging of brain with the β-amyloid probe,[11C]6-OH-BTA-1, in a transgenic mouse of Alzheimer's disease[J]. Eur J Nucl Med Mol Imaging, 2005, 32(5):593-600.
|
| [5] |
Klunk WE, Lopresti B J, Ikonomovic MD, et al. Binging of the positron emission tomography tracer Pittsburgh Compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain[J]. J Neurosci, 2005, 25(46):10598-10606.
|
| [6] |
Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B[J]. Ann Neurol, 2004, 55(3):306-319.
|
| [7] |
Kemppainen NM, Aalto S, Wilson IA, et al. Voxel-based analysis of PET amyloid ligand[nC]PIB uptake in Alzheimer disease[J]. Neurology, 2006, 67(9):1575-1580.
|
| [8] |
Mintun MA, Larossa GN, Sheline YI, et al.[11C]PIB in a nondemented population:potential antecedent marker of Alzheimer disease[J]. Neurology, 2006, 67(3):446-452.
|
| [9] |
Kemppainen NM, Aalto S, Wilson IA, et al. PET amyloid ligand[11C]PIB uptake is increased in mild cognitive impairment[J]. Neurology, 2007, 68(19):1603-1606.
|
| [10] |
Price JC, Klunk WE, Lopresti BJ, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B[J]. J Cereb Blood Flow Metab, 2005, 25(11):1528-1547.
|
| [11] |
Ziolko SK, Weissfeld LA, Klunk WE. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease[J]. Neuroimage, 2006, 33(1):94-102.
|
| [12] |
Edison P, Archer HA, Hinz R,et al. Amyloid, hypometabolism, and cognition in Alzheimer disease:an[11C]PIB and[^18F]FDG PET study[J]. Neurology, 2007, 68(7):501-508.
|
| [13] |
Scheinin NM, Tolvanen TK, Wilson IA, et al. Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans[J]. J Nucl Med, 2007, 48(1):128-133.
|